SIGNITT

  • Home

  • Individuals

  • Companies

  • About

  • Blog

  • Board Education

  • Contact

  • More

    Use tab to navigate through the menu items.
    Alexandra Morehouse
    • Jun 17
    • 1 min

    Alexandra Morehouse

    90
    Goodbye Millennials, Hello Gen Z – Dixie Kachiros
    • Oct 20, 2021
    • 1 min

    Goodbye Millennials, Hello Gen Z – Dixie Kachiros

    100
    Facing the Giant – Joyce Avedisian
    • Sep 24, 2021
    • 1 min

    Facing the Giant – Joyce Avedisian

    90
     
    Alexandra Morehouse

    Alexandra Morehouse

    Highly Effective Transformation Strategist A mission-driven collaborator and experienced board member, I bring my digital transformation...
    Goodbye Millennials, Hello Gen Z – Dixie Kachiros

    Goodbye Millennials, Hello Gen Z – Dixie Kachiros

    Gen Z live by the motto “You do you.” They give themselves and others permission to be different, and they express those differences how...
    Facing the Giant – Joyce Avedisian

    Facing the Giant – Joyce Avedisian

    I wrote a piece on leadership amongst a crisis. Crises either break or make you and your business. You must face the Giant head-on....
    • All Posts
    • Point of view
    Search
    Life Science Bio Entrepreneurship Seminar Series – Lorraine Marchand
    Maarten Schäfer

    Life Science Bio Entrepreneurship Seminar Series – Lorraine Marchand

    As moderator of the Columbia University Precision Medicine Life Sciences Seminar Series on Bioentrepreneurship, I interviewed Richard Scheller PhD, Chief Science Officer and Head of Theraepeutics at 23andMe.  In a fascinating discussion about a topic central to precision medicine, we examined the scientific and clinical basis of 23andMe and its consumer genetic test.   Dr. Scheller described the company’s business model, including the applications of the genetic data set to
     

    signitt

    • Facebook
    • Twitter
    • LinkedIn

    ©2022 by signitt. Proudly created with Wix.com